Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html

Study Counts

Type Study_count
Total_Studies 193
interventional 130
Observational 52
Registry 11

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 40
Other 33
Behavioral 10
Drug|placebo 7
Biological|Drug 6
Biological 4
Drug|Radiation 4
Biological|Drug|Procedure 3
Biological|Drug|Radiation 3
Device 3
Dietary Supplement 3
Drug|Procedure 3
Dietary Supplement|Drug|placebo 2
Genetic 2
Biological|Drug|Procedure|Radiation 1
Diagnostic Test|Drug 1
Dietary Supplement|Drug 1
Dietary Supplement|Drug|Procedure 1
Dietary Supplement|Other 1
Drug|Other 1
Drug|Other|Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 58
China 10
NA 7
Canada 5
France 5
Brazil 3
Ireland 3
Korea, Republic of 3
Netherlands 3
Taiwan 3
United Kingdom 3
United States|Canada 3
Belgium 2
Norway 2
Argentina 1
Austria|Greece|Italy|Netherlands|Slovenia|Spain|United Kingdom 1
China|Hong Kong 1
Colombia 1
Croatia 1
Czech Republic 1
Denmark 1
Egypt 1
Finland 1
Gabon 1
Germany 1
Israel 1
Italy 1
Lebanon 1
Spain 1
Sweden 1
Thailand 1
Turkey 1
United States|Australia|Canada|Netherlands|Puerto Rico|Switzerland 1
United States|Canada|Puerto Rico 1

Sites per Study

Site_count Study_Count
1 93
2 11
3 3
4 3
6 3
7 3
8 2
10 2
11 1
13 1
20 1
29 1
64 1
84 1
110 1
112 1
231 1
264 1

Phase

Phase Study_Count
N/A 58
Phase 2 19
Phase 1 15
Phase 4 15
Phase 3 11
Phase 1/Phase 2 8
Early Phase 1 2
Phase 2/Phase 3 2

Number of Arms

Number_of_Arms Count_of_Studies
1 31
2 61
3 13
4 3
6 2
16 1
NA 19

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 1.00 8.000 3.00 5.00000 20.00000 228 34.0000 10.0000
1st Qu. 7.75 101.000 15.75 6.00000 32.50000 246 125.5000 45.0000
Median 14.50 300.000 30.00 23.00000 50.00000 264 233.0000 153.5000
Mean 14.50 1659.759 31.50 24.71429 73.53333 264 285.7273 315.7143
3rd Qu. 21.25 951.500 40.00 30.00000 84.00000 282 312.0000 639.5000
Max. 28.00 21000.000 98.00 73.00000 296.00000 300 800.0000 1012.0000

Trial Group Type

group_type Group_Count
Experimental 122
Active Comparator 41
No Intervention 39
NA 19
Other 15
Placebo Comparator 14
Sham Comparator 1

Intervention Model

intervention_model Study_Count
Parallel Assignment 65
Single Group Assignment 37
NA 14
Sequential Assignment 6
Crossover Assignment 5
Factorial Assignment 3

Primary Purpose

primary_purpose Study_Count
Treatment 40
Health Services Research 26
Supportive Care 18
Prevention 15
Other 11
Basic Science 8
NA 5
Diagnostic 4
Screening 3

Observational Studies

Studies by Country

Country Study_Count
France 11
United States 10
Canada 6
NA 5
China 4
Switzerland 2
Thailand 2
Australia|Germany|Hong Kong|Japan|Korea, Republic of 1
Brazil 1
Denmark 1
Finland 1
Korea, Republic of 1
Norway 1
Romania 1
Singapore 1
Spain 1
Tanzania 1
United Kingdom 1
United States|Bolivia|Canada|Chile|India|United Kingdom 1

Sites per Study

Site_count Study_Count
1 39
2 1
3 1
4 1
5 1
6 2
7 2
9 1
10 1
18 1
29 1
48 1

Enrollment Metrics

Measure Observational
Min 10.00
1st Qu 140.25
Median 500.00
Mean 12368.25
3rd Qu 2200.00
Max 400000.00

Observation Model

observational_model Study_Count
Cohort 33
Case-Only 10
Other 4
Case-Control 3
NA 2

Time Perspective

time_perspective Study_Count
Prospective 31
Retrospective 10
Cross-Sectional 5
Other 5
NA 1

Registries

Studies by Country

Country Study_Count
China 4
France 2
United States 2
Argentina 1
Belgium 1
Thailand 1

Sites per Study

Site_count Study_Count
1 7
7 1
14 1
36 1
90 1

Enrollment Metrics

Measure Registries
Min 80.000
1st Qu 200.000
Median 2200.000
Mean 9141.455
3rd Qu 16800.000
Max 30400.000

Registry Model

observational_model Study_Count
Cohort 9
Case-Only 1
Other 1

Time Perspective

time_perspective Study_Count
Prospective 8
Cross-Sectional 1
Other 1
NA 1

Follow-up

target_duration Study_Count
1 Year 3
2 Weeks 1
2 Years 1
20 Months 1
36 Months 1
4 Months 1
5 Years 1
7 Days 1
8 Weeks 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03392311 Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis https://ClinicalTrials.gov/show/NCT03392311 Recruiting Guangdong Provincial Hospital of Traditional Chinese Medicine 2019-12-15
NCT03383133 Studies of Sulfur Metabolism in Humans https://ClinicalTrials.gov/show/NCT03383133 Active, not recruiting Albert Einstein College of Medicine 2019-03-31
NCT03943524 Drug Interactions in Outpatients. https://ClinicalTrials.gov/show/NCT03943524 Enrolling by invitation University of Buenos Aires 2020-06-01
NCT03338725 Effect and Associated Factors of the Clinical Pharmacy Model in the Incidence of Medical Errors https://ClinicalTrials.gov/show/NCT03338725 Recruiting Universidad de Antioquia 2019-05-30
NCT03272607 Reducing Post-discharge Adverse Drug Events Amongst the Elderly: a Multi-centre Electronic Deprescribing Intervention https://ClinicalTrials.gov/show/NCT03272607 Recruiting McGill University Health Centre/Research Institute of the McGill University Health Centre 2019-08-31
NCT03265613 Safety and Efficacy of Expanded Allogeneic AD-MSCs in Patients With Moderate to Severe Psoriasis https://ClinicalTrials.gov/show/NCT03265613 Active, not recruiting Guangdong Provincial Hospital of Traditional Chinese Medicine 2019-08-20
NCT03251144 Relative Mitochondrial Toxicity of Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil Fumarate (TDF) https://ClinicalTrials.gov/show/NCT03251144 Active, not recruiting University of California, Los Angeles 2022-07-01
NCT03212365 Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery https://ClinicalTrials.gov/show/NCT03212365 Completed University of Utah 2019-06-02
NCT03195946 Effects of Repeated Doses of Lu AF35700 on Drug Metabolizing Enzymes https://ClinicalTrials.gov/show/NCT03195946 Completed H. Lundbeck A/S 2018-01-03
NCT03189433 Efficacy and Safety Study of Ryanodex as Adjuvant Treatment in Subjects With Psychostimulant Drug-Induced Toxicity (PDIT) https://ClinicalTrials.gov/show/NCT03189433 Active, not recruiting Eagle Pharmaceuticals, Inc. 2018-12-31
NCT03183908 FLUAD vs. Fluzone High-Dose Study https://ClinicalTrials.gov/show/NCT03183908 Completed Duke University 2019-02-14
NCT03177174 Different Chemotherapy Protocols Combined With Intensity Modulated Radiation Therapy in Patients With Locally Advanced Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03177174 Completed Chinese PLA General Hospital 2020-01-01
NCT03123640 Improving Drug Safety in Emergency Patients -a Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT03123640 Active, not recruiting Diakonhjemmet Hospital 2018-05-16
NCT03112083 Safety and Tolerability of Krill Powder Supplement in Slightly Overweight People With Moderately Elevated Blood Pressure https://ClinicalTrials.gov/show/NCT03112083 Completed Olympic Seafood AS 2016-06-17
NCT03093818 PREemptive Pharmacogenomic Testing for Preventing Adverse Drug REactions https://ClinicalTrials.gov/show/NCT03093818 Recruiting Leiden University Medical Center 2020-07-31
NCT03029897 E-reporting of Adverse Drug Reactions by Patients in Relapsing-remitting Multiple Sclerosis https://ClinicalTrials.gov/show/NCT03029897 Completed University Hospital, Caen 2019-04-24
NCT02969343 Patient Safety Learning Laboratory: Making Acute Care More Patient-Centered https://ClinicalTrials.gov/show/NCT02969343 Completed Brigham and Women’s Hospital 2018-12-31
NCT02864030 PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment https://ClinicalTrials.gov/show/NCT02864030 Active, not recruiting Oncologia Medica dell’Ospedale Fatebenefratelli 2018-12-31
NCT02829307 A Positron Emission Tomography (PET) Imaging Study to Investigate the Biodistribution and Clearance of an Albumin Binding Domain Antibody (AlbudAb) GSK3128349 in Healthy Male Subjects https://ClinicalTrials.gov/show/NCT02829307 Completed GlaxoSmithKline 2017-01-27
NCT02811185 Registry Type Study to Monitor for Adverse Drug Reactions to Fedoruk Manufactured [F-18]-Fludeoxyglucose https://ClinicalTrials.gov/show/NCT02811185 Completed University of Saskatchewan 2017-01-31
NCT02805270 Impact of Medication Reconciliation Intervention on the Rate of Preventable Adverse Drug Events (ADEs) and Healthcare Utilization https://ClinicalTrials.gov/show/NCT02805270 Completed Sultan Qaboos University 2015-02-28
NCT02779530 CYP4A11 and CYP4F2 Gene Variants as Makers of Cardiovascular Adverse Events of Non-steroidal Anti-inflammatory Drugs https://ClinicalTrials.gov/show/NCT02779530 Completed University of Sao Paulo 2013-07-31
NCT02720328 Prevalence and Causes of Preventable and Serious Adverse Drug Reactions Related to the Use of Oral Anticoagulants https://ClinicalTrials.gov/show/NCT02720328 Completed Cliniques universitaires Saint-Luc- Université Catholique de Louvain 2016-01-31
NCT02719002 Studying the Performance of OCT C-scan in the Screening for Retinopathy Related to Synthetic Antimalarials https://ClinicalTrials.gov/show/NCT02719002 Active, not recruiting Fondation Ophtalmologique Adolphe de Rothschild 2020-12-31
NCT02667106 Phase I Pharmacokinetic Study of RX0041-2 https://ClinicalTrials.gov/show/NCT02667106 Completed Pharmaceutical Project Solutions, Inc. 2015-10-31
NCT02667054 Topical Anesthetic for Procedures Through the Nose https://ClinicalTrials.gov/show/NCT02667054 Completed Pharmaceutical Project Solutions, Inc. 2015-12-31
NCT02617680 Factors Affecting the Effective End-tidal Concentration of Desflurane Anaesthesia https://ClinicalTrials.gov/show/NCT02617680 Completed University Hospital Hradec Kralove 2015-12-31
NCT02482025 The Secure Messaging for Medication Reconciliation Tool (SMMRT) Trial https://ClinicalTrials.gov/show/NCT02482025 Recruiting VA Office of Research and Development 2020-06-30
NCT02457039 Acupuncture Prevents Chemobrain in Breast Cancer Patients https://ClinicalTrials.gov/show/NCT02457039 Completed The University of Hong Kong 2018-12-31
NCT02447679 Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma Recurrence https://ClinicalTrials.gov/show/NCT02447679 Completed Chang Gung Memorial Hospital 2017-01-31
NCT02413957 Medication Reconciliation in Comparison to an Extensive Medication Safety Check https://ClinicalTrials.gov/show/NCT02413957 Completed RWTH Aachen University 2016-01-31
NCT02378220 Pharmacogenetic Testing Among Home Health Patients https://ClinicalTrials.gov/show/NCT02378220 Completed Genelex Corporation 2016-02-29
NCT02297126 A Prospective Trial to Assess Cost and Clinical Outcomes of a Clinical Pharmacogenomic Program https://ClinicalTrials.gov/show/NCT02297126 Active, not recruiting Indiana University 2019-09-30
NCT02215395 An Open-label Study to Evaluate the Effects of Concurrent Administration of Vaginal Antimycotic Medication Miconazole Nitrate on the Pharmacokinetics of Nestorone and Ethinyl Estradiol Delivered by a Contraceptive Vaginal Ring in Normal Ovulating Women https://ClinicalTrials.gov/show/NCT02215395 Completed Population Council 2015-04-30
NCT02134587 Educational Intervention in Pharmacovigilance for Hospital Health Professionals https://ClinicalTrials.gov/show/NCT02134587 Completed Universidade Estadual Paulista Júlio de Mesquita Filho 2013-09-30
NCT02122965 The Effect of Medication Review in High-risk Emergency Department Patients https://ClinicalTrials.gov/show/NCT02122965 Completed University of British Columbia 2013-02-28
NCT02119078 Acute Care for Elders (ACE) Program at OHSU Hospital https://ClinicalTrials.gov/show/NCT02119078 Active, not recruiting Oregon Health and Science University 2017-06-30
NCT02097654 Clinical Trial of a New Software ENgine for the Assessment & Optimization of Drug and Non-drug Therapy in Older peRsons https://ClinicalTrials.gov/show/NCT02097654 Completed University College Cork 2018-02-28
NCT03384147 Metabolic Imprints of Alcoholic Beverages https://ClinicalTrials.gov/show/NCT03384147 Completed University of Copenhagen 2016-12-31
NCT02059044 Information Systems-enabled Outreach Program for Adverse Drug Events https://ClinicalTrials.gov/show/NCT02059044 Completed Ottawa Hospital Research Institute 2018-08-31
NCT01276314 Evaluation of TNF-α Blockade Effect in Patients With Severe Cutaneous Adverse Drug Reactions https://ClinicalTrials.gov/show/NCT01276314 Completed Chang Gung Memorial Hospital 2015-05-31
NCT02026453 Pharmacists and Pharmacy Technicians to Improve Admission Medication History Accuracy https://ClinicalTrials.gov/show/NCT02026453 Completed Cedars-Sinai Medical Center 2014-02-28
NCT02012712 Personal Health Records and Elder Medication Use Quality https://ClinicalTrials.gov/show/NCT02012712 Completed University of Iowa 2011-02-28
NCT01979380 Phase I Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics of KD101 in Healthy Male Subjects https://ClinicalTrials.gov/show/NCT01979380 Completed Kwang Dong Pharmaceutical co., ltd. 2014-05-31
NCT01897870 The Effect of a Pharmacist Home Visit on Drug-related Problems Post-discharge. https://ClinicalTrials.gov/show/NCT01897870 Completed Zorggroep Almere 2016-02-29
NCT04351308 Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade Osteosarcoma https://ClinicalTrials.gov/show/NCT04351308 Recruiting Peking University People’s Hospital 2022-09-01
NCT01861262 StO2 Performance Measured on Admission to the Emergency Department in the Assessment of Drug Poisoning https://ClinicalTrials.gov/show/NCT01861262 Completed University Hospital, Toulouse 2013-08-31
NCT01775839 Clinical Trial to Evaluate the Influence of Genotype and DDIs of Aspirin on the PK/PD of Clopidogrel and PK of Digoxin https://ClinicalTrials.gov/show/NCT01775839 Completed Seoul National University Hospital 2014-04-30
NCT01732302 Educational Intervention to Reduce Drug-related Hospitalizations in Elderly Primary Health Care Patients https://ClinicalTrials.gov/show/NCT01732302 Completed Karolinska Institutet 2013-09-30
NCT01679964 Sustained Virological Suppression and Improvement of Adverse Events of Switching to Raltegravir Study https://ClinicalTrials.gov/show/NCT01679964 Completed Lin, Hsi-Hsun, M.D. 2015-02-28
NCT01621373 Exploratory Propofol Dose Finding Study In Neonates https://ClinicalTrials.gov/show/NCT01621373 Completed Universitaire Ziekenhuizen Leuven 2014-07-31
NCT01602744 The Use of STOPP/START Criteria for Medication Intervention Among Elderly Population Living in a Geriatric Hospital https://ClinicalTrials.gov/show/NCT01602744 Completed Wolfson Medical Center 2013-09-30
NCT01531088 Enhancing the Detection and Management of Adverse Drug Events in Nursing Homes https://ClinicalTrials.gov/show/NCT01531088 Completed University of Pittsburgh 2014-04-30
NCT01467128 Adverse Drug Event Prevention Using Structured Pharmacist Review https://ClinicalTrials.gov/show/NCT01467128 Completed University College Cork 2012-06-30
NCT01467050 Prevention of Adverse Drug Events (ADEs) in Hospitalised Older Patients https://ClinicalTrials.gov/show/NCT01467050 Completed University College Cork 2012-06-30
NCT01337063 Multi-Center Medication Reconciliation Quality Improvement Study https://ClinicalTrials.gov/show/NCT01337063 Completed Brigham and Women’s Hospital 2014-09-30
NCT04345731 AHRQ- R01- OTC Labels for Older Adults https://ClinicalTrials.gov/show/NCT04345731 Active, not recruiting Michigan State University 2023-07-16
NCT04284553 Optimizing Electronic Health Record Prompts With Behavioral Economics to Improve Prescribing for Older Adults https://ClinicalTrials.gov/show/NCT04284553 Active, not recruiting Brigham and Women’s Hospital 2021-05-17
NCT04275024 Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Psoriasis Patients https://ClinicalTrials.gov/show/NCT04275024 Recruiting Guangdong Provincial Hospital of Traditional Chinese Medicine 2020-12-30
NCT04260113 Apatinib for Inoperable Advanced Chondrosarcoma https://ClinicalTrials.gov/show/NCT04260113 Active, not recruiting Peking University People’s Hospital 2020-01-01
NCT04254731 Effects of Switching From Racemic Methadone to R-methadone on QTc Intervals https://ClinicalTrials.gov/show/NCT04254731 Active, not recruiting Oslo University Hospital 2018-06-27
NCT04252326 The Knowledge, Attitudes and Practices of Healthcare Workers on Drug Hypersensitivity Reactions in Children https://ClinicalTrials.gov/show/NCT04252326 Active, not recruiting Saglik Bilimleri Universitesi 2019-06-01
NCT04226443 The Use of Midazolam and Remifentanil During Dialysis Access Procedures https://ClinicalTrials.gov/show/NCT04226443 Completed Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital 2016-04-15
NCT04138381 Selinexor in Combination With Imatinib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors. https://ClinicalTrials.gov/show/NCT04138381 Recruiting Grupo Espanol de Investigacion en Sarcomas 2022-04-16
NCT04120233 MW151-101: First-in-human Study of MW151 https://ClinicalTrials.gov/show/NCT04120233 Recruiting University of Kentucky 2021-01-31
NCT03955133 Polypharmacy Adverse Drug Reactions (PADRe): Nurse-led Intervention to Minimise Adverse Drug Reactions for Older Adults in Care Homes: a Quality Improvement Process Intervention https://ClinicalTrials.gov/show/NCT03955133 Active, not recruiting Swansea University 2020-12-31
NCT03887247 Reducing Concurrent Opioid-Benzodiazepine Prescriptions https://ClinicalTrials.gov/show/NCT03887247 Recruiting Walter Reed National Military Medical Center 2020-06-05
NCT03882541 Could Music be an Alternative to Sedation in Patients Treated Total Knee Arthroplasty With Regional Anesthesia? https://ClinicalTrials.gov/show/NCT03882541 Completed Consorci Sanitari de l’Anoia 2018-01-30
NCT03857100 Improving Wisely - Polypharmacy https://ClinicalTrials.gov/show/NCT03857100 Active, not recruiting Johns Hopkins University 2021-01-30
NCT03791580 Reducing High-Risk Geriatric Polypharmacy Via EHR Nudges: Pilot Phase https://ClinicalTrials.gov/show/NCT03791580 Active, not recruiting RAND 2019-06-01
NCT03779347 Schistosomiasis Diagnosis Using a CAA Antigen Test https://ClinicalTrials.gov/show/NCT03779347 Recruiting Centre de Recherche Médicale de Lambaréné 2021-04-01
NCT03748355 Using Pharmacogenetics to Identify Patients With Polypharmacy at Risk of Medication Adverse Effects https://ClinicalTrials.gov/show/NCT03748355 Completed Mayo Clinic 2020-01-02
NCT03745417 Efficacy and Safety of Expanded UCMSCs On Patients With Moderate to Severe Psoriasis https://ClinicalTrials.gov/show/NCT03745417 Recruiting Guangdong Provincial Hospital of Traditional Chinese Medicine 2019-02-28
NCT03725046 Impact of an Optimized Communication on the Readmission for Adverse Drug Event https://ClinicalTrials.gov/show/NCT03725046 Recruiting University Hospital, Montpellier 2022-05-31
NCT03705728 Automated Administration of Intravenous Compared With Inhalatory Anesthesia on the Occurrence of Postoperative Delirium https://ClinicalTrials.gov/show/NCT03705728 Recruiting Centre Clinical, France 2020-12-31
NCT03665402 A Pharamcogenomic Study for Isoniazid According to NAT2 Polymorphism Status https://ClinicalTrials.gov/show/NCT03665402 Completed Seoul National University Hospital 2018-12-31
NCT03640273 Efficacy and Adverse Effects of Prapchompoothaweep Remedy and Loratadine for Treatment in AR Patients https://ClinicalTrials.gov/show/NCT03640273 Completed Thammasat University 2018-01-04
NCT03638726 Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification https://ClinicalTrials.gov/show/NCT03638726 Recruiting Dar El Oyoun Hospital 2019-03-31
NCT03638375 TIL and Anti-PD1 in Metastatic Melanoma https://ClinicalTrials.gov/show/NCT03638375 Recruiting Leiden University Medical Center 2022-05-09
NCT03635684 Evaluation of Efficacy and Safety of Subcutaneous Acetaminophen https://ClinicalTrials.gov/show/NCT03635684 Completed Saint-Joseph University 2020-06-01
NCT03475589 Study on the Adverse Drug Reactions (ADRs) of Apatinib and Their Biomarker Correlations https://ClinicalTrials.gov/show/NCT03475589 Recruiting Sun Yat-sen University 2020-12-31
NCT03469063 Impact of AferBio® on Quality of Life and Chemotherapy Toxicity in Lung Cancer Patients https://ClinicalTrials.gov/show/NCT03469063 Recruiting Barretos Cancer Hospital 2020-02-28
NCT03461445 A Pilot Study to Evaluate Impact on Neurological Side Effects (Cognition, Memory, and Tremor) in Elderly (Age>65) Patients https://ClinicalTrials.gov/show/NCT03461445 Recruiting University of California, Davis 2020-12-31
NCT03438162 Impact of Pharmacotherapeutic Education on Medication Adherence and Adverse Outcomes in Type 2 Diabetes https://ClinicalTrials.gov/show/NCT03438162 Completed University Hospital Dubrava 2018-07-01
NCT03420469 Bupropion Stereoselective Disposition and CYP2D6-mediated Drug Interactions in Healthy Volunteers https://ClinicalTrials.gov/show/NCT03420469 Completed Indiana University 2019-05-01
NCT01239121 Regional Data Exchange to Improve Medication Safety https://ClinicalTrials.gov/show/NCT01239121 Completed VA Office of Research and Development 2015-06-30
NCT01179867 Using Novel Canadian Resources to Improve Medication Reconciliation at Discharge https://ClinicalTrials.gov/show/NCT01179867 Completed McGill University 2017-03-31
NCT01164137 Eliminating Risk of Preventable Adverse Drug Events at the Hospital-community Interface of Care https://ClinicalTrials.gov/show/NCT01164137 Completed Westview Physician Collaborative 2013-02-28
NCT01135680 Double-Blind Randomized Crossover Trial to Access Electrocardiogram Effects of HPN-100 https://ClinicalTrials.gov/show/NCT01135680 Completed Horizon Pharma Ireland, Ltd., Dublin Ireland 2010-09-30
NCT01091038 Improving Safety by Basic Computerizing Outpatient Prescribing https://ClinicalTrials.gov/show/NCT01091038 Completed Indiana University 2007-08-31
NCT01080547 Study Comparing Conventional and Fast Track Multi-Discipline Treatment Interventions for Colorectal Cancer https://ClinicalTrials.gov/show/NCT01080547 Completed Zhejiang University 2014-04-30
NCT03885388 Combination of Methotrexate(MTX) and Actinomycin(ACTD) in the Low Risk Gestational Trophoblastic Neoplasma （GTN） Patients With Score of 5-6 https://ClinicalTrials.gov/show/NCT03885388 Recruiting Women’s Hospital School Of Medicine Zhejiang University 2021-12-31
NCT02689076 Regional Data Exchange to Improve Care for Veterans After Non-VA Hospitalization https://ClinicalTrials.gov/show/NCT02689076 Completed VA Office of Research and Development 2020-03-31
NCT00780572 Implementation of Real-time ADE Surveillance and Decision Support https://ClinicalTrials.gov/show/NCT00780572 Completed VA Office of Research and Development 2010-09-30
NCT00743093 Aminotransferase Trends During Prolonged Acetaminophen Dosing https://ClinicalTrials.gov/show/NCT00743093 Completed Denver Health and Hospital Authority 2011-08-31
NCT00682773 Enhancing the Safety of Warfarin in Nursing Homes https://ClinicalTrials.gov/show/NCT00682773 Completed University of Massachusetts, Worcester 2008-12-31
NCT00491595 Phase I Clinical Study of Soy Isoflavones in Healthy, Post-Menopausal Women https://ClinicalTrials.gov/show/NCT00491595 Completed University of North Carolina, Chapel Hill NA
NCT00400946 Treatment of Acute Lymphoblastic Leukemia in Children https://ClinicalTrials.gov/show/NCT00400946 Completed Dana-Farber Cancer Institute 2014-08-31
NCT00324298 Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testicles https://ClinicalTrials.gov/show/NCT00324298 Completed National Cancer Institute (NCI) NA
NCT00317798 Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myeloma https://ClinicalTrials.gov/show/NCT00317798 Completed University of Rochester 2011-04-30
NCT00296036 Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer https://ClinicalTrials.gov/show/NCT00296036 Completed Alliance for Clinical Trials in Oncology 2009-07-31
NCT00245050 Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer https://ClinicalTrials.gov/show/NCT00245050 Completed Case Comprehensive Cancer Center 2008-04-30
NCT00229671 Medication Errors and Adverse Drug Events (ADEs) in Ambulatory Pediatrics https://ClinicalTrials.gov/show/NCT00229671 Completed Weill Medical College of Cornell University 2004-07-31
NCT00140504 Preventing Adverse Drug Events With PatientSite https://ClinicalTrials.gov/show/NCT00140504 Completed Dana-Farber Cancer Institute 2004-12-31
NCT00093353 N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma https://ClinicalTrials.gov/show/NCT00093353 Completed Children’s Hospital Los Angeles 2006-07-31
NCT00003252 Amifostine in Treating Patients With Cancer Who Have Neurological Changes Caused by Chemotherapy https://ClinicalTrials.gov/show/NCT00003252 Completed National Cancer Institute (NCI) NA
NCT00003068 High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer https://ClinicalTrials.gov/show/NCT00003068 Completed National Cancer Institute (NCI) NA
NCT00004176 Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00004176 Completed Washington University School of Medicine 2001-02-28
NCT00003580 Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and Cisplatin for Advanced Head and Neck Cancer https://ClinicalTrials.gov/show/NCT00003580 Completed National Cancer Institute (NCI) NA
NCT00003269 Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors https://ClinicalTrials.gov/show/NCT00003269 Completed Scripps Health 2001-01-31
NCT00004132 Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00004132 Completed National Cancer Institute (NCI) NA
NCT00005796 Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors https://ClinicalTrials.gov/show/NCT00005796 Completed Indiana University 2003-06-30
NCT00003144 Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors https://ClinicalTrials.gov/show/NCT00003144 Completed NYU Langone Health 2001-04-30
NCT00002818 High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies https://ClinicalTrials.gov/show/NCT00002818 Completed Virginia Commonwealth University 2001-02-28
NCT00002759 Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma https://ClinicalTrials.gov/show/NCT00002759 Completed National Cancer Institute (NCI) 2002-04-30
NCT00006345 Dexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell Lymphoma https://ClinicalTrials.gov/show/NCT00006345 Completed National Cancer Institute (NCI) NA
NCT00003089 Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00003089 Completed National Cancer Institute (NCI) NA
NCT00077311 Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00077311 Completed Alliance for Clinical Trials in Oncology 2006-07-31
NCT00075868 Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer https://ClinicalTrials.gov/show/NCT00075868 Completed Radiation Therapy Oncology Group 2006-08-31
NCT00003811 Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors https://ClinicalTrials.gov/show/NCT00003811 Completed Children’s Oncology Group 2004-10-31
NCT00003313 Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00003313 Completed Radiation Therapy Oncology Group 2002-07-31
NCT00006012 Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00006012 Completed Alliance for Clinical Trials in Oncology 2006-05-31
NCT00055718 Silymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving Chemotherapy https://ClinicalTrials.gov/show/NCT00055718 Completed National Cancer Institute (NCI) NA
NCT00028964 Combination Chemotherapy After Surgery With or Without Chinese Herbal Therapy to Treat Symptoms in Women With Breast Cancer https://ClinicalTrials.gov/show/NCT00028964 Completed University of California, San Francisco NA
NCT00024427 Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer https://ClinicalTrials.gov/show/NCT00024427 Completed Wellstat Therapeutics 2006-02-28
NCT00017004 Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia https://ClinicalTrials.gov/show/NCT00017004 Completed Gynecologic Oncology Group 2004-05-15
NCT00006105 Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer https://ClinicalTrials.gov/show/NCT00006105 Completed University of Chicago 2004-11-30
NCT00003268 Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT00003268 Completed National Cancer Institute (NCI) NA
NCT00002586 13-Cis Retinoic Acid With or Without Vitamin E for Prevention of Lung Cancer https://ClinicalTrials.gov/show/NCT00002586 Completed University of Colorado, Denver 2005-12-31
NCT00013143 Patient Profiling and Provider Feedback to Reduce Adverse Drug Events https://ClinicalTrials.gov/show/NCT00013143 Completed VA Office of Research and Development NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03825224 Evaluation of MyoStrainâ„¢ in Clinical Practice https://ClinicalTrials.gov/show/NCT03825224 Completed University of Kansas Medical Center 2019-11-15
NCT03316014 Adverse Drug Reactions in Pediatrics: Experience of a Regional Pharmacovigilance Center https://ClinicalTrials.gov/show/NCT03316014 Completed CHU de Reims 2014-12-31
NCT03280368 Adherence and Coagulation Assays in Dabigatran-treated Patients With Atrial Fibrillation https://ClinicalTrials.gov/show/NCT03280368 Completed Hospitalsenheden Vest 2019-11-30
NCT03258151 Association of Genetic Polymorphisms With Docetaxel-based Chemotherapy Toxicities in Chinese Solid Tumor Patients https://ClinicalTrials.gov/show/NCT03258151 Active, not recruiting Peking University First Hospital 2019-09-30
NCT03258099 Association of Genetic Polymorphisms With Capecitabine-based Chemotherapy Toxicities in Chinese Solid Tumor Patients https://ClinicalTrials.gov/show/NCT03258099 Active, not recruiting Peking University First Hospital 2019-10-31
NCT03227653 Neuropsychiatric Side Effects of Efavirenz in Children Living With HIV https://ClinicalTrials.gov/show/NCT03227653 Completed Radboud University 2017-12-31
NCT03211208 Assessing Antibiotic Induced Liver Injury for Stratification of Tuberculosis Patients https://ClinicalTrials.gov/show/NCT03211208 Recruiting University of Edinburgh 2020-04-30
NCT03210077 Romanian Entropy Clinical Study Network https://ClinicalTrials.gov/show/NCT03210077 Active, not recruiting Romanian Society of Anesthesia and Intensive Care 2019-12-31
NCT03135470 Pain Medication After Ambulatory Surgery https://ClinicalTrials.gov/show/NCT03135470 Recruiting Helsinki University Central Hospital 2019-12-31
NCT03042286 SAPhIRE Statin Adverse Drug Reaction https://ClinicalTrials.gov/show/NCT03042286 Recruiting National Heart Centre Singapore 2020-01-31
NCT02888834 Serious Adverse Drug Reaction and Their Preventability https://ClinicalTrials.gov/show/NCT02888834 Completed CHU de Reims 2013-05-31
NCT02852590 Relationship Between Adverse Drug Reactions and Unlicensed/ Off-label Drug Use in Hospitalized Children https://ClinicalTrials.gov/show/NCT02852590 Completed Hospices Civils de Lyon 2016-01-31
NCT02838212 Adverse Drug Reactions With Fatal Outcome https://ClinicalTrials.gov/show/NCT02838212 Completed Germans Trias i Pujol Hospital 2016-06-30
NCT02750137 Ametop - Friend and Foe A Prospective Study of the Incidence of Adverse Reactions With Ametop https://ClinicalTrials.gov/show/NCT02750137 Completed KK Women’s and Children’s Hospital 2015-05-31
NCT02609919 Assessment of Immediate Adverse Reactions From Dotarem in Children Under 2 Years of Age https://ClinicalTrials.gov/show/NCT02609919 Completed St. Louis University 2019-07-18
NCT02439658 Genetics of QT Prolongation With Antiarrhythmics https://ClinicalTrials.gov/show/NCT02439658 Recruiting Massachusetts General Hospital 2022-07-01
NCT02353455 Cells of Monocytic Origin as Surrogate Markers for Individual Drug Effects and Hepatotoxicity https://ClinicalTrials.gov/show/NCT02353455 Recruiting Ludwig-Maximilians - University of Munich 2020-03-31
NCT02239237 Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study https://ClinicalTrials.gov/show/NCT02239237 Completed China Academy of Chinese Medical Sciences 2018-06-30
NCT02162147 How Safe Are Our Pediatric Emergency Departments? https://ClinicalTrials.gov/show/NCT02162147 Completed Children’s Hospital of Eastern Ontario 2015-11-30
NCT02159209 The Drug Induced Renal Injury Consortium https://ClinicalTrials.gov/show/NCT02159209 Completed University of California, San Diego 2015-12-31
NCT02136017 Post-License Safety Evaluation of Influenza Virus Vaccine https://ClinicalTrials.gov/show/NCT02136017 Completed Sichuan Center for Disease Control and Prevention 2013-12-31
NCT01764204 Hospital Intensive Monitoring of Adverse Drug Reactions of Qingkailing Injection In The Next Two Years https://ClinicalTrials.gov/show/NCT01764204 Completed China Academy of Chinese Medical Sciences 2017-12-31
NCT04378881 Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Adults With Polypharmacy Using Data From Large Medicare and Commercially Insured Populations https://ClinicalTrials.gov/show/NCT04378881 Active, not recruiting Tabula Rasa HealthCare 2020-12-30
NCT01654055 International Prospective Study on Morphine-induced Adverse Drug Reactions in Emergency Departments. https://ClinicalTrials.gov/show/NCT01654055 Completed University Hospital, Toulouse 2012-08-31
NCT01354730 A Pharmacovigilance Study for AdimFlu-S (A/H1N1) Influenza Vaccine in Pregnant Women https://ClinicalTrials.gov/show/NCT01354730 Completed Adimmune Corporation 2011-04-30
NCT01354197 The Thai Surgical Intensive Care Study (Thai-SICU Study) https://ClinicalTrials.gov/show/NCT01354197 Completed Royal College of Anesthesiologists of Thailand 2012-11-30
NCT04395326 Monitoring of Metabolic Adverse Events of Second Generation Antipsychotics in a Naive Pediatric Population https://ClinicalTrials.gov/show/NCT04395326 Recruiting St. Justine’s Hospital 2024-12-31
NCT04339634 Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy https://ClinicalTrials.gov/show/NCT04339634 Active, not recruiting Tabula Rasa HealthCare 2020-07-07
NCT04279470 Chimeric Antigen Receptor T-cell and Cellular Therapies for the Treatment of cAncer or BLood Diseases: Evaluation of Reporting of Adverse Events https://ClinicalTrials.gov/show/NCT04279470 Active, not recruiting Groupe Hospitalier Pitie-Salpetriere 2025-01-01
NCT04249375 Integrating Pediatric Pharmacogenomic Testing Into the Canadian Health Care System https://ClinicalTrials.gov/show/NCT04249375 Recruiting University of British Columbia 2020-06-30
NCT04220918 Taste of Medicines in Children https://ClinicalTrials.gov/show/NCT04220918 Active, not recruiting Children’s Hospital of Philadelphia 2022-01-15
NCT04181775 Effectiveness of an ADE-related Hospitalization Risk Prediction Tool for Patients (ADE-RED) https://ClinicalTrials.gov/show/NCT04181775 Recruiting Methodist Health System 2020-11-30
NCT04154553 Pharmacogenetic Testing of Patients With Unwanted Adverse Drug Reactions or Therapy Failure https://ClinicalTrials.gov/show/NCT04154553 Recruiting University Hospital, Basel, Switzerland 2022-10-31
NCT03996941 Harm Reduction Program For Informal PrEP Users In A Community-based Setting (seguiPrEP) https://ClinicalTrials.gov/show/NCT03996941 Recruiting BCN Checkpoint 2024-09-01
NCT03953014 Pharmacogenetics of Antidepressant-Induced Disinhibition https://ClinicalTrials.gov/show/NCT03953014 Recruiting University of Calgary 2022-08-31
NCT03947034 Monitoring the Hyperammonaemia:TOXicity of Drugs (AmmoTOX) https://ClinicalTrials.gov/show/NCT03947034 Recruiting Groupe Hospitalier Pitie-Salpetriere 2020-05-30
NCT03938597 Investigation of Serious Adverse Events Following Vaccination Against Yellow Fever: Emphasis on Genetic Basis and Biological Markers https://ClinicalTrials.gov/show/NCT03938597 Recruiting The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 2022-01-30
NCT03808285 Denosumab Related Osteonecrossi of the Jaw : : an Emergent and Potentially Complex Bone and Joint Infection https://ClinicalTrials.gov/show/NCT03808285 Completed Hospices Civils de Lyon 2018-12-31
NCT03666845 Plasma Ropivacaine Concentrations After Sciatic Nerve Block in Patients With Chronic Kidney Disease https://ClinicalTrials.gov/show/NCT03666845 Recruiting Seoul National University Hospital 2020-04-30
NCT03659227 Drug Reactions Sampling (COLLECTIONTOXIDERMIES) https://ClinicalTrials.gov/show/NCT03659227 Recruiting Assistance Publique - Hôpitaux de Paris 2023-09-25
NCT03651778 GHB Poisoning and Poisoning Induced by Others https://ClinicalTrials.gov/show/NCT03651778 Recruiting University of Oslo 2020-12-31
NCT03623542 Adverse Drug Reactions in Older Subjects https://ClinicalTrials.gov/show/NCT03623542 Completed CHU de Reims 2011-11-01
NCT03492242 Immune CHeckpoint Inhibitors Monitoring of Adverse Drug ReAction https://ClinicalTrials.gov/show/NCT03492242 Completed Groupe Hospitalier Pitie-Salpetriere 2018-09-30
NCT03442010 Adverse Drug Events at Emergency Department https://ClinicalTrials.gov/show/NCT03442010 Completed University Hospital, Montpellier 2019-12-01
NCT01248377 Skin Testing and ELISPOT Assay in Patients With a History of Non-Immediate Reactions to Cephalosporins https://ClinicalTrials.gov/show/NCT01248377 Completed Chulalongkorn University 2011-05-31
NCT01058122 Collection, Evaluation and Assessment of Adverse Drug Reactions on the Oncology Ward https://ClinicalTrials.gov/show/NCT01058122 Completed University of Zurich 2008-09-30
NCT01050400 CYP2D6 Screening for Adverse Drug Reactions to Codeine in Breast Milk https://ClinicalTrials.gov/show/NCT01050400 Completed Lawson Health Research Institute 2012-12-31
NCT01614080 Outcome of Patients Treated by iv Rt-PA for Cerebral Ischaemia According to the Ratio Sc-tPA/Tc-tPA https://ClinicalTrials.gov/show/NCT01614080 Completed University Hospital, Lille 2014-11-30
NCT00414115 National Active Surveillance Network and Pharmacogenomics of Adverse Drug Reactions in Children https://ClinicalTrials.gov/show/NCT00414115 Recruiting University of British Columbia 2020-07-31
NCT00382434 Emergency Pharmacist Safety Study https://ClinicalTrials.gov/show/NCT00382434 Completed University of Rochester NA
NCT00224952 Pathogenesis of Adverse Drug Reactions https://ClinicalTrials.gov/show/NCT00224952 Completed Children’s Mercy Hospital Kansas City 2010-03-31
NCT00166608 Cytokines Polymorphisms and Acetaminophen Toxicity https://ClinicalTrials.gov/show/NCT00166608 Completed Arkansas Children’s Hospital Research Institute 2007-05-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03125603 Side Effects of Anti-PD-(L)-1 and Anti CTLA-A4 in the Non Small Cells Lung Cancer https://ClinicalTrials.gov/show/NCT03125603 Completed Cliniques universitaires Saint-Luc- Université Catholique de Louvain 2018-08-01
NCT02593916 Response to Medication Registry https://ClinicalTrials.gov/show/NCT02593916 Completed Intermountain Health Care, Inc. 2018-09-30
NCT02574988 Severe Cutaneous Adverse Reactions in Thailand https://ClinicalTrials.gov/show/NCT02574988 Recruiting Chulalongkorn University 2020-12-31
NCT02191358 YouScript IMPACT Registry https://ClinicalTrials.gov/show/NCT02191358 Completed Genelex Corporation 2015-08-31
NCT02094638 Post-Marketing Surveillance of the Tanreqing Injection: a Real World Study https://ClinicalTrials.gov/show/NCT02094638 Completed Peking University Third Hospital 2015-08-31
NCT01872520 Post-marketing Safety Surveillance of the Injection of DanShenDuoFenSuanYan A Real World Study https://ClinicalTrials.gov/show/NCT01872520 Completed Peking University Third Hospital 2015-09-30
NCT03994302 Monitoring the Antiphospholipid Syndrome:TOXicity of Drugs (APSTOX) https://ClinicalTrials.gov/show/NCT03994302 Recruiting Groupe Hospitalier Pitie-Salpetriere 2021-06-30
NCT03775798 Incidence of de Novo Hepatocellular Carcinoma After Antiviral Agents for HCV. https://ClinicalTrials.gov/show/NCT03775798 Recruiting Austral University, Argentina 2020-12-01
NCT03678337 Prevention and Pharmacological Management of Cardiac Adverse Drug Reactions Induced by Drugs Used in Oncology. https://ClinicalTrials.gov/show/NCT03678337 Recruiting University Hospital, Caen 2020-09-10
NCT03640884 Post-marketing Safety Surveillance of Xueshuantong-Injection : a Registry Study https://ClinicalTrials.gov/show/NCT03640884 Recruiting China Academy of Chinese Medical Sciences 2020-12-31
NCT03451734 Individualized Optimal Therapy of Antipsychotics https://ClinicalTrials.gov/show/NCT03451734 Recruiting Central South University 2018-10-01